rs113203706

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001080476.3(GRXCR1):​c.272G>T​(p.Gly91Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0044 in 1,613,854 control chromosomes in the GnomAD database, including 39 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0036 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0045 ( 34 hom. )

Consequence

GRXCR1
NM_001080476.3 missense

Scores

19

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 1.80

Publications

14 publications found
Variant links:
Genes affected
GRXCR1 (HGNC:31673): (glutaredoxin and cysteine rich domain containing 1) This gene is one of 60 loci associated with autosomal-recessive nonsyndromic hearing impairment. This gene encodes a protein which contains GRX-like domains; these domains play a role in the S-glutathionylation of proteins and may be involved in actin organization in hair cells. [provided by RefSeq, Sep 2010]
GRXCR1 Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 25
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0068248212).
BP6
Variant 4-42893538-G-T is Benign according to our data. Variant chr4-42893538-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 178379.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00355 (541/152238) while in subpopulation SAS AF = 0.00808 (39/4824). AF 95% confidence interval is 0.00608. There are 5 homozygotes in GnomAd4. There are 295 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRXCR1NM_001080476.3 linkc.272G>T p.Gly91Val missense_variant Exon 1 of 4 ENST00000399770.3 NP_001073945.1 A8MXD5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRXCR1ENST00000399770.3 linkc.272G>T p.Gly91Val missense_variant Exon 1 of 4 1 NM_001080476.3 ENSP00000382670.2 A8MXD5

Frequencies

GnomAD3 genomes
AF:
0.00356
AC:
542
AN:
152120
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000821
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00505
Gnomad ASJ
AF:
0.00835
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00787
Gnomad FIN
AF:
0.00424
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00453
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00464
AC:
1157
AN:
249094
AF XY:
0.00524
show subpopulations
Gnomad AFR exome
AF:
0.000646
Gnomad AMR exome
AF:
0.00284
Gnomad ASJ exome
AF:
0.00716
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00371
Gnomad NFE exome
AF:
0.00548
Gnomad OTH exome
AF:
0.00594
GnomAD4 exome
AF:
0.00449
AC:
6563
AN:
1461616
Hom.:
34
Cov.:
33
AF XY:
0.00475
AC XY:
3453
AN XY:
727126
show subpopulations
African (AFR)
AF:
0.000598
AC:
20
AN:
33454
American (AMR)
AF:
0.00280
AC:
125
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.00731
AC:
191
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39682
South Asian (SAS)
AF:
0.00820
AC:
707
AN:
86258
European-Finnish (FIN)
AF:
0.00427
AC:
228
AN:
53414
Middle Eastern (MID)
AF:
0.0109
AC:
63
AN:
5768
European-Non Finnish (NFE)
AF:
0.00438
AC:
4869
AN:
1111830
Other (OTH)
AF:
0.00596
AC:
360
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
419
838
1256
1675
2094
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
180
360
540
720
900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00355
AC:
541
AN:
152238
Hom.:
5
Cov.:
32
AF XY:
0.00396
AC XY:
295
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.000818
AC:
34
AN:
41560
American (AMR)
AF:
0.00504
AC:
77
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.00835
AC:
29
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00808
AC:
39
AN:
4824
European-Finnish (FIN)
AF:
0.00424
AC:
45
AN:
10620
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00453
AC:
308
AN:
68010
Other (OTH)
AF:
0.00284
AC:
6
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
27
55
82
110
137
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00425
Hom.:
7
Bravo
AF:
0.00322
TwinsUK
AF:
0.00351
AC:
13
ALSPAC
AF:
0.00285
AC:
11
ESP6500AA
AF:
0.00124
AC:
5
ESP6500EA
AF:
0.00383
AC:
32
ExAC
AF:
0.00506
AC:
612
Asia WGS
AF:
0.00260
AC:
9
AN:
3476
EpiCase
AF:
0.00611
EpiControl
AF:
0.00646

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:6
Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

GRXCR1: BP4, BS2 -

Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 07, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 26, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 16, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 20137774, 20137778) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Apr 30, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Gly91Val in Exon 01 of GRXCR1: This variant is not expected to have clinical sig nificance because it has been identified in 0.4% (25/6762) of European American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs113203706). -

GRXCR1-related disorder Benign:1
May 06, 2021
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Autosomal recessive nonsyndromic hearing loss 25 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.64
CADD
Benign
7.1
DANN
Benign
0.92
DEOGEN2
Benign
0.050
T
Eigen
Benign
-0.83
Eigen_PC
Benign
-0.73
FATHMM_MKL
Benign
0.44
N
LIST_S2
Benign
0.44
T
M_CAP
Benign
0.0079
T
MetaRNN
Benign
0.0068
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.90
L
PhyloP100
1.8
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-0.38
N
REVEL
Benign
0.051
Sift
Benign
0.34
T
Sift4G
Benign
0.42
T
Polyphen
0.0
B
Vest4
0.19
MVP
0.21
MPC
0.040
ClinPred
0.0040
T
GERP RS
1.1
Varity_R
0.046
gMVP
0.70
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113203706; hg19: chr4-42895555; API